跳至主要内容
临床试验/NCT02962752
NCT02962752已完成不适用

Pharmacodynamic Profile of 'Blackadder' Blackcurrant Juice Effects Upon the Monoamine Axis in Humans

Northumbria University0 个研究点目标入组 8 人开始时间: 2012年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
8
主要终点
Change from baseline Monoamine Oxidase B - Activity

研究概览

简要总结

The current study uses a double-blind, placebo-controlled, randomised cross- over design to assess the pharmacodynamics of the platelet MAO-B inhibition, plasma prolactin levels and blood glucose levels after consumption of a single serve of 'Blackadder' blackcurrant juice.

详细描述

There is emerging evidence which supports health benefits of consuming blackcurrant fruit, including improvements to cognitive performance, modulation of blood flow, regulation of blood glucose and inhibition of enzymes underpinning normal cognitive function. Of particular relevance is our previous demonstration of inhibition of MAO-A and B after consumption of a New Zealand 'Blackadder' blackcurrant juice drink in man.

In an attempt to establish a "therapeutic window" on which future nutritional interventions can be based, the current study will assess the pharmacodynamics of MAO-B inhibition, plasma prolactin levels and venous blood glucose profile following consumption of the 'Blackadder' blackcurrant juice. The trial will utilise a 500mg dose of the 'Blackadder' juice (equivalent to ~100g of fresh fruit) which was shown to have MAO inhibitory effects in our previous report and effects will be measured in a cohort of healthy male adults.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Aged 18-35
  • Non- smoker
  • No history of metabolic disease

排除标准

  • Diagnosis of blood-borne disease
  • Diagnosed history of any psychiatric disorder
  • Aged under 18 or over 35 years
  • BMI above 30 kg/m2 or below 17 kg/m2,
  • Diagnosis of diabetes or current use of prescription or over-the-counter drugs

结局指标

主要结局

Change from baseline Monoamine Oxidase B - Activity

时间窗: 15, 30, 45 60, 100, 120, 150, 180 and 240 minutes and 24h post dose.

Platelet monamine oxidase- B activity as measured by the Invitrogen amplex red assay

Change from baseline peripheral prolactin levels

时间窗: 15, 30, 45 60, 100, 120, 150, 180 and 240 minutes and 24h post dose.

次要结局

  • Change from baseline postprandial blood glucose(15, 30, 45 60, 100, 120, 150, 180 and 240 minutes and 24h post dose.)

研究者

申办方类型
Other
责任方
Sponsor

相似试验